These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2628133

  • 21. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
    Tsai YT, Lee FY, Lin HC, Chang TT, Lay CS, Wang SS, Kong CW, Lee SD, Lo KJ.
    Hepatology; 1989 Sep; 10(3):283-7. PubMed ID: 2759546
    [Abstract] [Full Text] [Related]

  • 22. Clinical vs haemodynamic response to drugs in portal hypertension.
    McCormick PA, Patch D, Greenslade L, Chin J, McIntyre N, Burroughs AK.
    J Hepatol; 1998 Jun; 28(6):1015-9. PubMed ID: 9672178
    [Abstract] [Full Text] [Related]

  • 23. Effect of sublingual isosorbide dinitrate on wedged hepatic venous pressure in cirrhotics with portal hypertension.
    Qureshi H, Zuberi SJ, Faruqui A.
    Indian J Gastroenterol; 1988 Jul; 7(3):161-2. PubMed ID: 3397139
    [No Abstract] [Full Text] [Related]

  • 24. Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.
    Jones AL, Bangash IH, Walker J, Simpson KJ, Finlayson ND, Hayes PC.
    Gut; 1995 Jan; 36(1):104-9. PubMed ID: 7890211
    [Abstract] [Full Text] [Related]

  • 25. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
    Bellis L, Berzigotti A, Abraldes JG, Moitinho E, García-Pagán JC, Bosch J, Rodés J.
    Hepatology; 2003 Feb; 37(2):378-84. PubMed ID: 12540788
    [Abstract] [Full Text] [Related]

  • 26. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J, Picabea E, Gamen M, Villavicencio R, Bordato J, Bessone F, Tanno H, Palazzi J, Sarano H, Pozzoli L.
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.
    Hori N, Okanoue T, Sawa Y, Itoh Y, Mori T, Takami S, Kashima K.
    J Gastroenterol; 1994 Aug; 29(4):460-8. PubMed ID: 7951857
    [Abstract] [Full Text] [Related]

  • 31. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis.
    Sarin SK, Sethi KK, Nanda R.
    Gut; 1987 Mar; 28(3):260-6. PubMed ID: 3570030
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Portal venous blood flow unaltered in cirrhotic patients given metoclopramide injections.
    Ohta M, Tomikawa M, Hashizume M, Ueno K, Tanoue K, Sugimachi K.
    Ital J Gastroenterol; 1995 Jun; 27(5):239-43. PubMed ID: 8541573
    [Abstract] [Full Text] [Related]

  • 34. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
    Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G, Angeli P, Gatta A.
    Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis.
    Zoli M, Marchesini G, Brunori A, Cordiani MR, Pisi E.
    Hepatology; 1986 Jul; 6(6):1248-51. PubMed ID: 2878867
    [Abstract] [Full Text] [Related]

  • 37. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
    Morillas RM, Planas R, Cabré E, Galán A, Quer JC, Feu F, García Pagán JC, Bosch J, Gassull MA.
    Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651
    [Abstract] [Full Text] [Related]

  • 38. Duplex Doppler ultrasonographic comparison of the effects of propranolol and isosorbide-5-mononitrate on portal hemodynamics.
    Tincani E, Cioni G, Cristani A, D'Alimonte P, Vignoli A, Abbati G, Ventura P, Romagnoli R, Ventura E.
    J Ultrasound Med; 1993 Sep; 12(9):525-9. PubMed ID: 8107184
    [Abstract] [Full Text] [Related]

  • 39. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP, Maev IV, Andreev NG.
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [Abstract] [Full Text] [Related]

  • 40. [The effect of glucagon on portal hemodynamics in patients with liver cirrhosis].
    Cervinka J, Kaláb M, Jedlicka J, Petrtýl J, Marecek Z.
    Cas Lek Cesk; 1991 Feb 22; 130(8):231-2. PubMed ID: 2025894
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.